Skip to main navigation
Skip to main content
Skip to Footer
Global
Novartis Site Directory
Our Services
Assay Development for Intended Use
Clinical Trial Testing
Companion Diagnostics Solutions
Partnership Opportunitites
Portfolio
Our Company
Who We Are
Leadership
Join Us
Contact
Our Capabilities
Technical
Project Management
Data Management
Global Logistics
Portfolio
Lab Partnerships
Companion Diagnostics Partners
Service Inquiries
Our Experience
Navigate Team
Publications
Services Metrics
Quality
Search
News Archive
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Stories
Filter By
2014
February
Media Release
/
Feb 25, 2014
Read More
Media Release
/
Feb 25, 2014
Novartis shareholders approve all resolutions proposed by Novartis Board of Directors
Read More
Media Release
/
Feb 24, 2014
Novartis provides second US university with Bexsero® to help protect students and staff against potentially deadly meningitis B disease
Read More
Media Release
/
Feb 21, 2014
Novartis shows continued commitment in Japan with Lucentis® approval in fourth Japanese indication, diabetic macular edema
Read More
Media Release
/
Feb 19, 2014
Novartis investigational compound LDE225 met primary endpoint in pivotal trial for patients with advanced basal cell carcinoma
Read More
Media Release
/
Feb 17, 2014
Novartis expands cancer immunotherapy research program with acquisition of CoStim
Read More
January
Media Release
/
Jan 29, 2014
Read More
Media Release
/
Jan 29, 2014
Read More
Media Release
/
Jan 29, 2014
Novartis delivers strong sales and innovation in 2013; underlying business performance reinforces growth prospects
Read More
Media Release
/
Jan 27, 2014
Novartis recognized among world's most sustainable companies in Corporate Knights Global 100
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
…
Page
22
of 5
Page
23
of 5
Current page
24
of 5
Page
25
of 5
Page
26
of 5
…
Next page
next ›
Last page
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Jump to Comments
Print
Save
You are here
Home
›